These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 500185)

  • 1. Adherence of Actinomyces viscosus T14V and T14AV to hydroxyapatite surfaces in vitro and human teeth in vivo.
    Wheeler TT; Clark WB; Birdsell DC
    Infect Immun; 1979 Sep; 25(3):1066-74. PubMed ID: 500185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of physicochemical parameters on adsorption of Actinomyces viscosus to hydroxyapatite surfaces.
    Wheeler TT; Clark WB; Lane MD; Grow TE
    Infect Immun; 1983 Mar; 39(3):1095-101. PubMed ID: 6840836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative estimates of bacterial affinities and adsorption sites on hydroxyapatite surfaces.
    Clark WB; Bammann LL; Gibbons RJ
    Infect Immun; 1978 Mar; 19(3):846-53. PubMed ID: 640732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the adsorptive behavior of human strains of Actinomyces viscosus and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Qureshi JV; Gibbons RJ
    Infect Immun; 1981 Jan; 31(1):261-6. PubMed ID: 7216448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibril-mediated adherence of Actinomyces viscosus to saliva-treated hydroxyapatite.
    Wheeler TT; Clark WB
    Infect Immun; 1980 May; 28(2):577-84. PubMed ID: 7399676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14.
    Cisar JO; Vatter AE; McIntire FC
    Infect Immun; 1978 Jan; 19(1):312-9. PubMed ID: 624593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
    Peros WJ; Gibbons RJ
    Infect Immun; 1981 Apr; 32(1):111-7. PubMed ID: 7216480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae.
    Clark WB; Wheeler TT; Cisar JO
    Infect Immun; 1984 Feb; 43(2):497-501. PubMed ID: 6141143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus.
    Kuramitsu HK; Paul A
    Infect Immun; 1980 Jul; 29(1):83-90. PubMed ID: 6772577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of surface composition of Actinomyces viscosus T14V and T14AV.
    Powell JT; Fischlschweiger W; Birdsell DC
    Infect Immun; 1978 Dec; 22(3):934-44. PubMed ID: 730385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces.
    Gibbons RJ; Hay DI
    Infect Immun; 1988 Feb; 56(2):439-45. PubMed ID: 2892794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
    Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
    Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
    Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
    Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langmuir and scatchard parameters do not describe the binding of Actinomyces viscosus to saliva-treated hydroxyapatite.
    Moncla BJ; Halfpap L; Birdsell DC
    J Gen Microbiol; 1985 Oct; 131(10):2619-26. PubMed ID: 4067574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomyces viscosus colonization of mouse teeth.
    Crawford PC; Clark WB
    J Dent Res; 1986 Feb; 65(2):105-8. PubMed ID: 3455963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteroides gingivalis-Actinomyces viscosus cohesive interactions as measured by a quantitative binding assay.
    Schwarz S; Ellen RP; Grove DA
    Infect Immun; 1987 Oct; 55(10):2391-7. PubMed ID: 3653983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomyces adsorption mediated by type-1 fimbriae.
    Clark WB; Wheeler TT; Lane MD; Cisar JO
    J Dent Res; 1986 Sep; 65(9):1166-8. PubMed ID: 2874164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fimbria-specific antibodies in serum and saliva of mice immunized with Actinomyces viscosus T14V fimbriae.
    Crawford PC; Clark WB
    Infect Immun; 1986 Nov; 54(2):507-15. PubMed ID: 2876962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorbed salivary proline-rich protein 1 and statherin: receptors for type 1 fimbriae of Actinomyces viscosus T14V-J1 on apatitic surfaces.
    Gibbons RJ; Hay DI; Cisar JO; Clark WB
    Infect Immun; 1988 Nov; 56(11):2990-3. PubMed ID: 2902013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.